http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2020 Financial Results and Host a Conference Call on Tuesday, March 16, 2021
-
Yield10 Bioscience to Present at Bank of America 2021 Virtual Global Agriculture & Materials Conference on March 4, 2021
-
Yield10 Bioscience, Inc. (YTEN) Announces Warrant Exercises for Proceeds of $3.8 million
-
Yield10 Bioscience Announces Warrant Exercises for Proceeds of $3.8 million
-
Yield10 Bioscience Announces Closing of $12.7 Million Public Offering
-
Yield10 Bioscience, Inc. (YTEN) Prices 1.04M Share Offering at $12.25/Sh
-
Yield10 Bioscience Announces Pricing of $12.7 Million Public Offering
-
Yield10 Bioscience Announces Proposed Public Offering of Common Stock
-
Yield10 Bioscience, Inc. (YTEN) Achieves Proof-of-Concept Milestone for Producing PHA Bioplastic in Field Grown Camelina Plants
-
Yield10 Bioscience Announces Achievement of Proof-of-Concept Milestone for Producing PHA Bioplastic in Field Grown Camelina Plants
-
Yield10 Bioscience Researcher Dr. Meghna Malik to Present at the 4th CRISPR AgBio Congress 2020 Virtual Event
-
Yield10 Bioscience Announces Third Quarter 2020 Financial Results
-
Yield10 Bioscience Announces Collaboration with Rothamsted Research to Develop Advanced Technology for Producing Omega-3 Nutritional Oils in Camelina
-
Yield10 Bioscience to Announce Third Quarter 2020 Financial Results and Host a Conference Call on Thursday, November 12, 2020
-
Yield10 Bioscience Announces Start of Field Tests of Winter Camelina Varieties
-
Yield10 Bioscience Announces Completion of Harvesting for 2020 Field Test Program to Evaluate Novel Yield and Compositional Traits in Camelina and Canola
-
Yield10 Bioscience Announces Participation at The H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020 (Virtual Conference)
-
Yield10 Bioscience to Present at the LD 500 Virtual Conference on September 2, 2020
-
Yield10 Bioscience Announces Closing of $4.0 Million Public Offering, Including Exercise of the Over-Allotment Option, and Concurrent $1.7 Million Private Placement
-
Yield10 Bioscience, Inc. (YTEN) Prices 835K Common Share Offering at $4.25/Sh; Announces Concurrent Private Placement
-
Yield10 Bioscience Announces Pricing of $5.2 Million Public Offering and Concurrent Private Placement
-
Yield10 Bioscience, Inc. (YTEN) Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
-
Yield10 Bioscience Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
-
Yield10 Bioscience, Inc. (YTEN) Obtains Positive Response from USDA-APHIS on Regulated Status of its CRISPR Genome-Edited C3007 Trait in Canola; Plans U.S. Field Tests for 2021
-
Yield10 Bioscience Obtains Positive Response from USDA-APHIS on Regulated Status of its CRISPR Genome-Edited C3007 Trait in Canola; Plans U.S. Field Tests for 2021
-
Yield10 Bioscience Announces Second Quarter 2020 Financial Results
-
Yield10 Bioscience, Inc. (YTEN) Signs Research Agreement with GDM to Evaluate New Yield Traits in Soybean
-
Yield10 Bioscience Signs Research Agreement with GDM to Evaluate New Yield Traits in Soybean
-
Yield10 Bioscience to Announce Second Quarter 2020 Financial Results and Host a Conference Call on Tuesday, August 11, 2020
-
Yield10 Bioscience Announces Spring Planting of 50 Acres of Wild-Type Spring Camelina to Support Business Development Plans
-
Yield10 Bioscience Announces Successful Evaluation of Emergence and Establishment in Field Tests of Winter Camelina Varieties
-
Yield10 Bioscience Begins 2020 Field Test Program to Evaluate Novel Yield Traits in Camelina and Canola
-
Yield10 Bioscience Announces First Quarter 2020 Financial Results
-
Yield10 Bioscience Secures Regulatory Permits for U.S. and Canadian Sites and Announces Plans for 2020 Field Test Program in Camelina and Canola
-
Yield10 Bioscience to Announce First Quarter 2020 Financial Results and Host a Conference Call on Thursday, May 14, 2020
-
Yield10 Bioscience Announces Change of 2020 Annual Meeting of Stockholders to a Virtual Meeting
-
Yield10 Bioscience, Inc. (YTEN) Announces Positive Response from USDA-APHIS on Regulatory Status of iCRISPR Genome-Edited C3007 Trait in Camelina
-
Yield10 Bioscience Obtains Positive Response from USDA-APHIS on Regulatory Status of its CRISPR Genome-Edited C3007 Trait in Camelina, Paving the Way for U.S. Field Tests
-
Yield10 Bioscience Announces Fourth Quarter and Full Year 2019 Financial Results
-
Yield10 Bioscience Announces Results of 2019 Field Test Program
-
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2019 Financial Results and Host a Conference Call on Thursday, March 19, 2020
-
Yield10 Bioscience Achieves Key Milestones in Early Development Program in Corn to Evaluate Novel Traits
-
Yield10 Bioscience Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement
-
Yield10 Bioscience Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement
-
Yield10 Bioscience Submits "Am I Regulated?" Letter to USDA-APHIS BRS for CRISPR Genome-Edited C3007 in Camelina to Pave the Way for U.S. Field Tests
-
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present at the 7th Plant Genomics & Gene Editing Congress
-
Yield10 Bioscience Signs Research Agreement with J. R. Simplot to Evaluate New Traits to Produce High Yielding, Sustainable Potato Crop
-
Yield10 Bioscience Expands Research License with Bayer for Evaluation of a Novel C3004 Yield Trait Gene in Soybean
-
Yield10 Bioscience Announces Notice of Allowance for U.S. Patent Covering Crop Yield Trait C4001
-
Yield10 Bioscience Granted U.S. Patent Covering Crop Yield Trait C3003

